Controversially, Styczen et al. [141] enrolled 208 patients with liver metastasis of CRC and analyzed the expression status of HER2 and HER3, suggesting that the expression status of HER2 and HER3 in primary tumors (especially HER3) is closely related to metachronous liver metastasis. This evidence concerns the gene ERBB2 and metastasis.